Abstract
A comparison was made of the histological findings for myocardial tissue of heterotopic transplanted rat hearts administered with FK506. ACI rats were used as donors and Lewis rats as recipients. FK506 was used for 6 days except for group I (control group). Group II received 0.32 mg/kg/day of FK506 from the day of operation while group III was given the same dosage from the 4th day after transplantation. Group IV was given 1.28 mg/kg/day of the agent from the day of grafting and group V received the same dose from the 4th postoperative day. The graft survival time was longer for all groups given FK506, but was significantly longer only for groups administered with FK506 from the day of operation. Histological studies performed 10 and 20 days after transplantation showed that a moderate rejection was seen in about half of the grafts receiving FK506 from the 4th day after grafting. An ultra-structural study of these cases showed that infiltrating large lymphocytes still remained in the interstitial tissues and that the cytoplasmic organelles of the myocytes had been focally destroyed. These results suggest that, although FK506 suppressed any further rejection, the effect might be limited and the myocardial changes of the cardiac graft might persist even after administration for ongoing rejection.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Ochiai T, Nakajima K, Nagata M, Hori S, Asano T, Isono K (1987) Studies of the induction and maintenance of long-term graft acceptance by treatment with FK506 in heterotopic cardiac allotransplantation in rats. Transplantation 44:734–738
Armitage JM, Kormos RL, Morita S, Fung J, Marrone GC, Hardesty RL, Griffith BP, Starzl TE (1992) Clinical trial of FK506 immunosuppression in adult cardiac transplantation. Ann Thorac Surg 54:205–211
Ochiai T, Nagata M, Nakajima K, Suzuki T, Sakamoto K, Enomoto K, Gunji Y, Uematsu T, Goto T, Hori S, Kenmochi T, Nakagouri T, Asano T, Isono K, Hamaguchi K, Tsuchida H, Nakahara K, Inamura N, Goto T (1987) Studies of the effects of FK506 on renal allografting in the beagle dog. Transplantation 44:729–733
Murase N, Kim DG, Todo S, Cramer DV, Fung JJ, Starzl TE (1990) Suppression of allograft rejection with FK-506. I. Prolonged cardiac and liver survival in rats following shortcourse therapy. Transplantation 50:186–189
Murase N, Kim DG, Todo S, Cramer DV, Fung J, Starzl TE (1990) FK506 suppression of heart and liver allograft rejection. II. The induction of graft acceptance in rats. Transplantation 50:739–744
Ono K, Lindsey ES (1969) Improve technique of heart transplantation in rats. J Thorac Cardiovasc Surg 57:225–229
Karnovsky MJ (1965) A formaldehyde-glutaraldehyde fixative of high osmolarity for use in electron microscopy. J Cell Biol 27:137A
Billingham ME (1982) Diagnosis of cardiac rejection by endomyocardial biopsy. Heart Transplant 1:25–30
Billingham ME, Cary NRB, Hammond ME, Kemnitz J, Marboe C, McCallister HA, Snovar DC, Winters GL, Zerbe A (1990) A working formulation for the standardization of nomenclature in the diagnosis of heart and lung rejection. Heart rejection study group. J Heart Transplant 9:587–593
Starzl TE, Todo S, Fung J, Demetris AJ, Venkataramanan R, Jain A (1989) FK506 for liver, kidney, and pancreas transplantation. Lancet 28:100–1004
Todo S, Fung JJ, Starzl TE, Tzakis A, Demetris AJ, Kormos R, Jain A, Alessiani M, Takaya S, Shapiro R (1990) Liver, kidney, and thoracic organ transplantation under FK506. Ann Surg 112:295–307
Sawada S, Suzuki G, Kawase Y, Takaku F (1987) Novel immunosuppressive agent, FK506. In vitro effects on the cloned T cell activation. J Immunol 139:1797–1803
Tocci MJ, Matkovich DA, Collier KA, Kwok P, Dumont F, Lin S, Degudicibus S, Siekierka JJ, Chin J, Hutchinson NI (1989) The immunosuppressant FK506 selectively inhibits expression of early T cells activation genes. J Immunol 143:718–726
Bierer BE, Schreiber SL, Burakoff SJ (1990) Mechanisms of immunosuppression by FK506. Transplantation 49:1168–1170
Author information
Authors and Affiliations
Additional information
This work was supported by a Ministry of Education Grant (A) 03770873.
Rights and permissions
About this article
Cite this article
Hisatomi, K., Sato, T., Nishimi, M. et al. Limited effectiveness of FK506 administration for ongoing rejection in heterotopic rat heart transplantation. Surg Today 24, 254–257 (1994). https://doi.org/10.1007/BF02032897
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02032897